C07D 498 - Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms

Patents for C07D 498 - Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms (21,960)
11/2006
11/21/2006	US7138531 Preparation and use of carbohydrate-based bicyclic ring structures with antimicrobial and cytostatic activity
11/21/2006	US7138395 Interleukin-1β converting enzyme inhibitors
11/16/2006	WO2006120545A1 4' amino linked macrolides useful for the treatment of microbial infections
11/16/2006	WO2006120478A2 Quinoline derivatives as neurokinin receptor antagonists
11/16/2006	WO2006119975A1 Thienopyrroles as antiviral agents
11/16/2006	US20060258724 Anticoagulants; cardiovascular disorders; atherosclerosis; antiarthritic agents; Alzheimer's disease; anticancer agents
11/16/2006	US20060258701 glucokinase-activating effect and is useful as a therapeutic agent for diabetes mellitus; 3-(4-methoxy-phenylsulfanyl)-6-(4H-[1,2,4]triazol-3-yl-sulfanyl)-N-([1,3,4]thiadiazol-2-yl)-2-pyridine carboxamide
11/16/2006	US20060258659 Heterocyclic compounds and their uses as therapeutic agents
11/16/2006	US20060258658 Triazole compounds useful as protein kinase inhibitors
11/16/2006	US20060258652 Beta-blockers having antioxidant and no-donor activity
11/16/2006	US20060258648 9-Azabicyclo'3.3.1 inon-6-ee derivatives with a heteroatom at the 3-position as renin inhibitors
11/16/2006	US20060258637 Fused polycyclic compounds
11/16/2006	CA2607874A1 Quinoline derivatives as neurokinin receptor antagonists
11/16/2006	CA2607421A1 Thienopyrroles as antiviral agents
11/16/2006	CA2606847A1 Antibacterial agents
11/15/2006	EP1720886A1 Macrolides and methods for producing same
11/15/2006	EP1720859A2 Chemokine receptor antagonists
11/15/2006	EP1720839A1 Pyridazinones as antagonists of a4 integrins
11/15/2006	EP1670778B1 Rearranged pentanols, a method for the production thereof, and their use as antiphlogistics
11/15/2006	EP1206493B1 Monoclonal antibodies to tacrolimus and immunoassay methods for tacrolimus
11/15/2006	CN1863835A Process for making amide acetals
11/15/2006	CN1863806A 4-biphenylsubstituted pyrazolidin-3,5-dione derivatives
11/15/2006	CN1861607A Fluorane kind derivant, its preparation and application
11/14/2006	US7135575 P38 inhibitors and methods of use thereof
11/14/2006	US7135495 Indole derivatives
11/14/2006	US7135478 Analogues of camptothecin, their use as medicaments and the pharmaceutical compositions containing them
11/14/2006	US7135470 Thienopyridazines as IKK inhibitors
11/14/2006	US7135468 Antibacterial compounds
11/14/2006	CA2244363C Synthetic derivatives of rapamycin as multimerizing agents for chimeric proteins with immunophilin-derived domains
11/14/2006	CA2128955C Tricyclic benzazepine vasopressin antagonists
11/14/2006	CA2128493C Aminobenzoic acid derivatives
11/09/2006	US20060252931 New CGRP-antagonists, process for preparing them and their use as pharmaceutical compositions
11/09/2006	US20060252778 Compounds for the treatment of inflammatory disorders
11/09/2006	US20060252759 (5R,8aR)-5-methyl-1,3,5,6,7,8,8a,9-octahydro-2-oxa-4,4b,7-triaza-cyclopenta[b]fluorene; serotonin (5HT2C) receptor agonists; reductiv amination, acylation
11/09/2006	US20060252758 sodium channel modulators such as 1'-pentylspiro[furo[2,3-f][1,3]benzodioxole-7,3'-pyrrolo[2,3-b]pyridin]-2'(1'H)-one, useful as for the treatment of nervous system disorders, cardiovascular disorders, muscular disorders and as neuroprotectants or as analgesics
11/08/2006	EP1719773A1 Fused heterotetracyclic compounds and use tehreof as hcv polymerase inhibitor
11/08/2006	EP1718654A1 Resolution of racemates of methyl alpha-5- 4,5,6,7-tetrahydr o 3,2-c thienopyridyl -(2-chlorophenil)acetate
11/08/2006	EP1718626A1 Sulfonylpyrrolodine modulators of androgen receptor fuction and method
11/08/2006	EP1718611A1 3-3-di-substituted-oxindoles as inhibitors of translation initiation
11/08/2006	EP1718299A1 Heterocyclic gaba-a subtype selective receptor modulators
11/08/2006	EP1587810B1 Novel substituted 1,4\|benzodioxino 2,3-e\|isoindole derivatives, method for preparing same and pharmaceutical compositions containing same
11/08/2006	EP1021190B1 Amid derivatives as growth hormone release promotors
11/08/2006	CN1858052A Quinolone carboxylate compounds and their preparing method and use
11/07/2006	US7132533 Tricyclic compounds protein kinase inhibitors for enhancing the efficacy of anti-neoplastic agents and radiation therapy
11/07/2006	US7132429 Sulfonamido ether substituted imidazoquinolines
11/07/2006	US7132426 Fused-aryl and heteroaryl derivatives as modulators of metabolism and the prophylaxis and treatment of disorders related thereto
11/07/2006	CA2186023C Process for preparing 2-piperazine carboxylic acid derivatives
11/02/2006	WO2006114706A1 Triazole derivatives as vasopressin antagonists
11/02/2006	US20060247269 Thienopyridone derivatives as kinase inhibitors
11/02/2006	US20060247268 N-sulfonylaminothiazole
11/02/2006	US20060247237 Macrocyclic quinazoline derivatives as antiproliferative agents
11/02/2006	US20060247217 Tricyclic protein kinase inhibitors
11/02/2006	EP1716156A2 Chemokine ccr5 receptor modulators
11/02/2006	EP1716119A1 Analogs of benzoquinone-containing ansamycins for the treatment of cancer
11/02/2006	EP0885883B1 Fused heterocyclic compounds and pharmaceutical applications thereof
11/01/2006	CN1856500A Method of purifying macrolides
11/01/2006	CN1856498A Thienopyridine and furopyridine kinase inhibitors
11/01/2006	CN1854139A Levo ofloxacin derivative, its production and use
10/2006
10/31/2006	US7129262 Effective to reduce the viability and/or to sensitize the cancer to an anti-cancer agent.
10/31/2006	US7129071 Recombinant methods and materials for producing epothilone and epothilone derivatives
10/31/2006	CA2350560C Novel type condensed pyridazinone compounds
10/31/2006	CA2174731C Rapamycin derivatives useful as immunosuppressants
10/26/2006	WO2006113768A1 Fermentation broth extraction of k-252a
10/26/2006	WO2006112549A1 Fused heterocyclic compound
10/26/2006	WO2006111321A1 Azole derivatives in the form of lipase and phospholipase inhibitors
10/26/2006	WO2006075255A3 Anti-inflamatory macrolide conjugates
10/26/2006	WO2006065448A3 Topoisomerase inhibitors and prodrugs
10/26/2006	WO2005095384A8 Pyrazine derivatives and pharmaceutical use thereof as adenosine antagonists
10/26/2006	US20060241132 Spiro derivatives and adhesion molecule inhibitors comprising the same as active ingredient
10/26/2006	US20060241110 2-(Imidazol-1-ylalkyl)-3H-quinazolin-4-one derivatives; mitotic kinesin KSP inhibitors; anticarcinogenic, antiinflammatory, and antiproliferative agents
10/26/2006	US20060241103 Inhibiting polymerization of FtsZ in a bacterium by contactng with 2,3-diphenyl-6-(ethoxycarbonylamino)-8-(4-(diethylamino)-1-methylbutylamino)pyrido[2,3-b]pyrazine, optionally linked to a permeability enhancer to allow the compound to cross the bacterium's cell envelope
10/26/2006	US20060241099 Use of 2-thia-dibenzo[e,h]azulenes for the manufacture of pharmaceutical formulations for the treatment and prevention of central nervous system diseases and disorders
10/26/2006	DE102005018389A1 Azolderivate als Inhibitoren von Lipasen und Phospholipasen Azole derivatives as inhibitors of lipases and phospholipases
10/26/2006	CA2606301A1 Azole derivatives in the form of lipase and phospholipase inhibitors
10/26/2006	CA2605778A1 Fused heterocyclic compound
10/26/2006	CA2604408A1 Fermentation broth extraction of k-252a
10/25/2006	EP1715019A1 Single-layer organic el device
10/25/2006	EP1713814A1 Bicyclic pyrazolo-fused compounds as protein kinase modulators
10/25/2006	EP1713813A2 POLYMORPHIC FORMS OF A GABA sb A /sb AGONIST
10/25/2006	EP1313476B1 Sgk3 used as diagnostic and therapeutic target
10/25/2006	CN1852748A Azepine derivatives as pharmaceutical agents
10/25/2006	CN1852714A Quinazoline analogs as receptor tyrosine kinase inhibitors
10/25/2006	CN1852712A Dual NK1/NK3 antagonists for treating schizophrenia
10/24/2006	US7125989 Hetero diels-alder adducts of pentacene as soluble precursors of pentacene
10/24/2006	US7125983 L-nucleic acid derivatives and process for the synthesis thereof
10/24/2006	US7125907 Thiolactones
10/24/2006	US7125899 Microtubule-stabilizing agents useful in the treatment of a variety of cancers
10/24/2006	US7125896 Thiophene carboxamide compounds as inhibitors of enzyme IKK-2
10/24/2006	US7125854 Bicyclic carbohydrates as antiprotozoal bioactive for the treatment of infections caused by parasites
10/24/2006	CA2264598C 1,2,3,4-tetrahydro-benzofuro[3,2-c]pyridine derivatives
10/24/2006	CA2259031C Androgen receptor modulator compounds and methods
10/24/2006	CA2167584C Aza spiro compounds acting on the cholinergic system with muscarinic agonist activity
10/19/2006	WO2006110917A2 Spiro-oxindole compounds and their uses as therapeutic agents
10/19/2006	WO2006109156A1 Oxazolidinone derivatives as antimicrobials
10/19/2006	WO2006108828A1 (1, 10b-dihydro-2-(aminoalkyl- phenyl)-5h-pyraz0l0 [1,5-c] [1,3] benz0xazin-5-yl) phenyl methanone derivatives as hiv viral repliation inhibitors
10/19/2006	WO2006085212A3 Condensed isoxaline derivatives as inhibitors of phosphodiesterase type-iv
10/19/2006	WO2006081178A3 Antibacterial agents
10/19/2006	WO2006068932A3 Rapamycin analogues and the uses thereof in the treatment of neurological, proliferative, and inflammatory disorders
10/19/2006	US20060235069 Benzamide modulators of metabotropic glutamate receptors
10/19/2006	US20060235060 Hetero-polycyclic compounds, and coloring matters, pigments, dyes, color-changing material compositions, and color-changing films, made by using the compounds

1 ... 83 84 85 86 87 88 89 90 91 92 93 94 95 96 97 98 99 100 101 102 103 ... 220